News/ News/ R&D Biogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s ruling Richard Staines Alzheimer's, Biogen, ophthalmology, X-linked retinitis pigmentosa 0 Comment Biogen has downbeat news about its gene therapy for the rare inherited eye disease, X-linked retinitis pigmentosa, announcing Share X Biogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s ruling https://pharmaphorum.com/news/biogens-eye-disease-gene-therapy-fails-ahead-of-fda-alzheimers-ruling/